APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Microarray

A microarray is a tiny, bio-compatible silicon chip capable of rapid identification and precise multiplexed analysis of nucleic acids (DNA/RNA).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A microarray is a tiny, bio-compatible silicon chip capable of rapid identification and precise multiplexed analysis of nucleic acids (DNA/RNA).

Selected research

Market Outlook & Growth Opportunities

Global DNA Microarray Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchDNA Microarray Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Microarray Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal DNA Microarray Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Microarray Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Microarray Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

A microarray is a tiny, bio-compatible silicon chip capable of rapid identification and precise multiplexed analysis of nucleic acids (DNA/RNA).

Global DNA Microarray key players include Illumnia, Inc, Affymetrix, Agilent Technologies, etc. Global top three manufacturers hold a share about 55%.

USA is the largest market, with a share over 90%, followed by Europe and Others, both have a share over 5 percent.

Read the full market overview

In terms of product, Oligonucleotide DNA Microarrays (oDNA) is the largest segment, with a share over 95%. And in terms of application, the largest application is Gene Expression, followed by Genotyping.

This report provides an overview of the global DNA Microarray market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Microarray and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Microarray revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Microarray market.

DNA Microarray Segment by Company

Illumnia

Affymetrix

Agilent Technologies

Roche NimbleGen

Sengenics

Arrayit

Applied Microarrays

Biometrix Technology

Savyon Diagnostics

Scienion AG

WaferGen

DNA Microarray Segment by Type

Oligonucleotide DNA Microarrays (oDNA)

Complementary DNA Microarrays (cDNA)

DNA Microarray Segment by Application

Gene Expression

Genotyping

Other Usage

Genome Cytogenetics

DNA Microarray Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Microarray status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA Microarray key companies, revenue, market share, and recent developments.

3. To split the DNA Microarray breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA Microarray market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Microarray significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Microarray competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Microarray market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Microarray and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Microarray.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Microarray industry.

Chapter 3: Detailed analysis of DNA Microarray company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA Microarray in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA Microarray in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Microarray Industry Trends Table 2. DNA Microarray Industry Drivers Table 3. DNA Microarray Industry Opportunities and Challenges Table 4. DNA Microarray Industry Restraints Table 5. Global DNA Microarray Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Microarray Revenue Share by Company (2021-2026) Table 7. Global DNA Microarray Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA Microarray Key Company Manufacturing Base & Headquarters Table 9. Global DNA Microarray Company, Product Type & Application Table 10. Global DNA Microarray Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA Microarray by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oligonucleotide DNA Microarrays (oDNA) Table 15. Significant Companies of Complementary DNA Microarrays (cDNA) Table 16. Global DNA Microarray Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global DNA Microarray Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global DNA Microarray Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global DNA Microarray Sales Value Share by Type (2021-2026) Table 20. Global DNA Microarray Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Gene Expression Table 22. Significant Companies of Genotyping Table 23. Significant Companies of Other Usage Table 24. Significant Companies of Genome Cytogenetics Table 25. Global DNA Microarray Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global DNA Microarray Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global DNA Microarray Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global DNA Microarray Sales Value Share by Application (2021-2026) Table 29. Global DNA Microarray Sales Value Share by Application (2027-2032) Table 30. Global DNA Microarray Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global DNA Microarray Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global DNA Microarray Sales Value Share by Region (2021-2026) Table 33. Global DNA Microarray Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global DNA Microarray Sales Value Share by Region (2027-2032) Table 35. Global DNA Microarray Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global DNA Microarray Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global DNA Microarray Sales Value Market Share by Country (2021-2026) Table 38. Global DNA Microarray Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global DNA Microarray Sales Value Market Share by Country (2027-2032) Table 40. Illumnia Company Information Table 41. Illumnia Business Overview Table 42. Illumnia DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Illumnia DNA Microarray Product Portfolio Table 44. Illumnia Recent Development Table 45. Affymetrix Company Information Table 46. Affymetrix Business Overview Table 47. Affymetrix DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Affymetrix DNA Microarray Product Portfolio Table 49. Affymetrix Recent Development Table 50. Agilent Technologies Company Information Table 51. Agilent Technologies Business Overview Table 52. Agilent Technologies DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Agilent Technologies DNA Microarray Product Portfolio Table 54. Agilent Technologies Recent Development Table 55. Roche NimbleGen Company Information Table 56. Roche NimbleGen Business Overview Table 57. Roche NimbleGen DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Roche NimbleGen DNA Microarray Product Portfolio Table 59. Roche NimbleGen Recent Development Table 60. Sengenics Company Information Table 61. Sengenics Business Overview Table 62. Sengenics DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Sengenics DNA Microarray Product Portfolio Table 64. Sengenics Recent Development Table 65. Arrayit Company Information Table 66. Arrayit Business Overview Table 67. Arrayit DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Arrayit DNA Microarray Product Portfolio Table 69. Arrayit Recent Development Table 70. Applied Microarrays Company Information Table 71. Applied Microarrays Business Overview Table 72. Applied Microarrays DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Applied Microarrays DNA Microarray Product Portfolio Table 74. Applied Microarrays Recent Development Table 75. Biometrix Technology Company Information Table 76. Biometrix Technology Business Overview Table 77. Biometrix Technology DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Biometrix Technology DNA Microarray Product Portfolio Table 79. Biometrix Technology Recent Development Table 80. Savyon Diagnostics Company Information Table 81. Savyon Diagnostics Business Overview Table 82. Savyon Diagnostics DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Savyon Diagnostics DNA Microarray Product Portfolio Table 84. Savyon Diagnostics Recent Development Table 85. Scienion AG Company Information Table 86. Scienion AG Business Overview Table 87. Scienion AG DNA Microarray Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Scienion AG DNA Microarray Product Portfolio Table 89. Scienion AG Recent Development Table 90. WaferGen Company Information Table 91. WaferGen Business Overview Table 92. WaferGen DNA Microarray Sales (k units), Value (US$ Million), Price (M USD) and Gross Margin (2021-2026) Table 93. WaferGen DNA Microarray Product Portfolio Table 94. WaferGen Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. DNA Microarray Product Image Figure 2. Global DNA Microarray Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Microarray Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Microarray Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oligonucleotide DNA Microarrays (oDNA) Image Figure 8. Complementary DNA Microarrays (cDNA) Image Figure 9. Global DNA Microarray Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global DNA Microarray Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global DNA Microarray Sales Value Share by Type (2021-2032) Figure 12. Gene Expression Image Figure 13. Genotyping Image Figure 14. Other Usage Image Figure 15. Genome Cytogenetics Image Figure 16. Global DNA Microarray Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global DNA Microarray Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global DNA Microarray Sales Value Share by Application (2021-2032) Figure 19. Global DNA Microarray Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global DNA Microarray Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America DNA Microarray Sales Value (2021-2032) & (US$ Million) Figure 22. North America DNA Microarray Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe DNA Microarray Sales Value (2021-2032) & (US$ Million) Figure 24. Europe DNA Microarray Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific DNA Microarray Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific DNA Microarray Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America DNA Microarray Sales Value (2021-2032) & (US$ Million) Figure 28. South America DNA Microarray Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa DNA Microarray Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa DNA Microarray Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt DNA Microarray Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt DNA Microarray Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt DNA Microarray Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Oligonucleotide DNA Microarrays (oDNA)
  • Complementary DNA Microarrays (cDNA)
Applications
  • Gene Expression
  • Genotyping
  • Other Usage
  • Genome Cytogenetics
Companies covered
  • Illumnia
  • Affymetrix
  • Agilent Technologies
  • Roche NimbleGen
  • Sengenics
  • Arrayit
  • Applied Microarrays
  • Biometrix Technology
  • Savyon Diagnostics
  • Scienion AG
  • WaferGen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Microarray Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Microarray Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA Microarray Market Dynamics
  1. 2.1 DNA Microarray Industry Trends
  2. 2.2 DNA Microarray Industry Drivers
  3. 2.3 DNA Microarray Industry Opportunities and Challenges
  4. 2.4 DNA Microarray Industry Restraints
3 DNA Microarray Market by Company
  1. 3.1 Global DNA Microarray Company Revenue Ranking in 2025
  2. 3.2 Global DNA Microarray Revenue by Company (2021-2026)
  3. 3.3 Global DNA Microarray Company Ranking (2024-2026)
  4. 3.4 Global DNA Microarray Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA Microarray Company Product Type and Application
  6. 3.6 Global DNA Microarray Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA Microarray Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA Microarray Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA Microarray Market by Type
  1. 4.1 DNA Microarray Type Introduction
  2. 4.1.1 Oligonucleotide DNA Microarrays (oDNA)
  3. 4.1.2 Complementary DNA Microarrays (cDNA)
  4. 4.2 Global DNA Microarray Sales Value by Type
  5. 4.2.1 Global DNA Microarray Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Microarray Sales Value by Type (2021-2032)
  7. 4.2.3 Global DNA Microarray Sales Value Share by Type (2021-2032)
5 DNA Microarray Market by Application
  1. 5.1 DNA Microarray Application Introduction
  2. 5.1.1 Gene Expression
  3. 5.1.2 Genotyping
  4. 5.1.3 Other Usage
  5. 5.1.4 Genome Cytogenetics
  6. 5.2 Global DNA Microarray Sales Value by Application
  7. 5.2.1 Global DNA Microarray Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global DNA Microarray Sales Value by Application (2021-2032)
  9. 5.2.3 Global DNA Microarray Sales Value Share by Application (2021-2032)
6 DNA Microarray Regional Value Analysis
  1. 6.1 Global DNA Microarray Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Microarray Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA Microarray Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA Microarray Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Microarray Sales Value (2021-2032)
  7. 6.3.2 North America DNA Microarray Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA Microarray Sales Value (2021-2032)
  10. 6.4.2 Europe DNA Microarray Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA Microarray Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA Microarray Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA Microarray Sales Value (2021-2032)
  16. 6.6.2 South America DNA Microarray Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA Microarray Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA Microarray Sales Value Share by Country, 2025 VS 2032
7 DNA Microarray Country-level Value Analysis
  1. 7.1 Global DNA Microarray Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Microarray Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA Microarray Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA Microarray Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA Microarray Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA Microarray Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA Microarray Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA Microarray Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA Microarray Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA Microarray Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA Microarray Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA Microarray Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA Microarray Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA Microarray Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA Microarray Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA Microarray Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA Microarray Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA Microarray Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA Microarray Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA Microarray Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA Microarray Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA Microarray Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA Microarray Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA Microarray Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA Microarray Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA Microarray Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA Microarray Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA Microarray Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA Microarray Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA Microarray Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA Microarray Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA Microarray Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA Microarray Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA Microarray Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA Microarray Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA Microarray Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA Microarray Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA Microarray Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA Microarray Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA Microarray Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA Microarray Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA Microarray Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA Microarray Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA Microarray Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA Microarray Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA Microarray Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA Microarray Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA Microarray Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA Microarray Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA Microarray Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA Microarray Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA Microarray Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA Microarray Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA Microarray Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA Microarray Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA Microarray Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA Microarray Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA Microarray Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA Microarray Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA Microarray Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA Microarray Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA Microarray Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA Microarray Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA Microarray Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA Microarray Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA Microarray Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA Microarray Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA Microarray Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA Microarray Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA Microarray Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA Microarray Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA Microarray Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA Microarray Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA Microarray Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA Microarray Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA Microarray Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA Microarray Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA Microarray Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA Microarray Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA Microarray Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA Microarray Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA Microarray Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA Microarray Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA Microarray Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA Microarray Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA Microarray Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA Microarray Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA Microarray Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumnia
  2. 8.1.1 Illumnia Company Information
  3. 8.1.2 Illumnia Business Overview
  4. 8.1.3 Illumnia DNA Microarray Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumnia DNA Microarray Product Portfolio
  6. 8.1.5 Illumnia Recent Developments
  7. 8.2 Affymetrix
  8. 8.2.1 Affymetrix Company Information
  9. 8.2.2 Affymetrix Business Overview
  10. 8.2.3 Affymetrix DNA Microarray Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Affymetrix DNA Microarray Product Portfolio
  12. 8.2.5 Affymetrix Recent Developments
  13. 8.3 Agilent Technologies
  14. 8.3.1 Agilent Technologies Company Information
  15. 8.3.2 Agilent Technologies Business Overview
  16. 8.3.3 Agilent Technologies DNA Microarray Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies DNA Microarray Product Portfolio
  18. 8.3.5 Agilent Technologies Recent Developments
  19. 8.4 Roche NimbleGen
  20. 8.4.1 Roche NimbleGen Company Information
  21. 8.4.2 Roche NimbleGen Business Overview
  22. 8.4.3 Roche NimbleGen DNA Microarray Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche NimbleGen DNA Microarray Product Portfolio
  24. 8.4.5 Roche NimbleGen Recent Developments
  25. 8.5 Sengenics
  26. 8.5.1 Sengenics Company Information
  27. 8.5.2 Sengenics Business Overview
  28. 8.5.3 Sengenics DNA Microarray Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sengenics DNA Microarray Product Portfolio
  30. 8.5.5 Sengenics Recent Developments
  31. 8.6 Arrayit
  32. 8.6.1 Arrayit Company Information
  33. 8.6.2 Arrayit Business Overview
  34. 8.6.3 Arrayit DNA Microarray Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Arrayit DNA Microarray Product Portfolio
  36. 8.6.5 Arrayit Recent Developments
  37. 8.7 Applied Microarrays
  38. 8.7.1 Applied Microarrays Company Information
  39. 8.7.2 Applied Microarrays Business Overview
  40. 8.7.3 Applied Microarrays DNA Microarray Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Applied Microarrays DNA Microarray Product Portfolio
  42. 8.7.5 Applied Microarrays Recent Developments
  43. 8.8 Biometrix Technology
  44. 8.8.1 Biometrix Technology Company Information
  45. 8.8.2 Biometrix Technology Business Overview
  46. 8.8.3 Biometrix Technology DNA Microarray Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biometrix Technology DNA Microarray Product Portfolio
  48. 8.8.5 Biometrix Technology Recent Developments
  49. 8.9 Savyon Diagnostics
  50. 8.9.1 Savyon Diagnostics Company Information
  51. 8.9.2 Savyon Diagnostics Business Overview
  52. 8.9.3 Savyon Diagnostics DNA Microarray Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Savyon Diagnostics DNA Microarray Product Portfolio
  54. 8.9.5 Savyon Diagnostics Recent Developments
  55. 8.10 Scienion AG
  56. 8.10.1 Scienion AG Company Information
  57. 8.10.2 Scienion AG Business Overview
  58. 8.10.3 Scienion AG DNA Microarray Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Scienion AG DNA Microarray Product Portfolio
  60. 8.10.5 Scienion AG Recent Developments
  61. 8.11 WaferGen
  62. 8.11.1 WaferGen Company Information
  63. 8.11.2 WaferGen Business Overview
  64. 8.11.3 WaferGen DNA Microarray Revenue and Gross Margin (2021-2026)
  65. 8.11.4 WaferGen DNA Microarray Product Portfolio
  66. 8.11.5 WaferGen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst